Head Of Early Assets, Hematology

AstraZeneca

Gaithersburg, MD, US
Base: $270,221 - $405,332; bonus/equity: short-ter...
Md required with hematology training
10+ years biopharma industry experience
Early asset commercial strategy expertise
The role operates at the commercial-R&D interface to shape the early hematology pipeline from preclinical through early clinical development

Job Summary

  • The role operates at the commercial-R&D interface to shape the early hematology pipeline from preclinical through early clinical development.
  • Candidates must lead early commercial strategy across hematology modalities including bispecific T-cell engagers and antibody-drug conjugates.
  • The position offers a base pay range of $270,221 to $405,332 along with short-term incentives and equity-based long-term programs.

Matching Summary

The role operates at the commercial-R&D interface to shape the early hematology pipeline from preclinical through early clinical development.

Salary

Base: $270,221 - $405,332; Bonus/Equity: Short-term incentive bonus and equity-based long-term incentive program eligible; Benefits: 401(k), paid vacation, health/dental/vision coverage

Skills & Requirements

Must-have

  • MD required with hematology training
  • 10+ years biopharma industry experience
  • Early asset commercial strategy expertise
  • Hematology modalities TCE ADC small molecules
  • Matrix leadership influencing without authority

Nice-to-have

  • Board certification in hematology oncology
  • Advanced degree MBA MSc PhD
  • Experience with CMC manufacturing logistics
  • Strong storytelling for senior stakeholders
  • Network with clinical experts and payers

Key Requirements

  • MD degree mandatory
  • Hematology-trained physician preferred
  • 10+ years biopharma experience
  • Direct exposure to TCE ADC modalities
  • Proven matrix leadership experience

Work Rights

Not specified

Tailored Resume

Cover Letter